Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Asclepio ; 73(2): p570, Dic 30, 2021. tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-217885

RESUMO

Este artículo revisa el periodo transcurrido por Malaspina en Madrid tras su “viaje alrededor del mundo”, hasta su detención en noviembre de 1795. A la luz de fuentes hasta ahora ignoradas por la historiografía malaspiniana, se analiza la participación de Malaspina en una disputa literaria en el Diario de Madrid, donde llegó a publicar bajo seudónimo cuatro cartas filosóficas sobre la belleza que constituyen un antecedente directo de su Meditación filosófica, su obra más personal, escrita en presidio tras su arresto. Por último, se analiza la relación de Malaspina con su vecina madrileña Fernanda O’Connock, marquesa de Matallana, mujer vinculada a la oposición política a Godoy y destacada agente conspiradora contra el primer ministro en dicho periodo, quien muy posiblemente tuvo un papel mucho más activo de lo que hasta ahora se le había reconocido en la conspiración Malaspina. (AU)


This article reviews the period spent by Malaspina in Madrid after his “voyage around the world”, until his arrest in November 1795. Exploring sources hitherto ignored by Malaspinian historiography, the article focuses on Malaspina’s participation in a literary dispute which took place in the Diario de Madrid, where he published under pseudonym four philosophical letters on Beauty. These letters constitute the direct antecedent of his Meditation on Beauty, his most personal work, written in prison after his arrest. Lastly, the paper analyses Malaspina’s relationship with his neighbour in Madrid, Fernanda O’Connock, Marchioness of Matallana, a woman linked to the political opposition to Manuel Godoy and an outstanding conspirator agent against the Prime Minister, who very possibly played a much more active role than previously recognised in the so-called “Malaspina conspiracy”.(AU)


Assuntos
Humanos , Masculino , Beleza , Estética , Correspondência como Assunto , Cidades , Natureza , Espanha
2.
Clín. investig. arterioscler. (Ed. impr.) ; 32(3): 101-110, mayo-jun. 2020. tab
Artigo em Espanhol | IBECS | ID: ibc-193354

RESUMO

ANTECEDENTES Y OBJETIVO: Los datos sobre la distribución de las dislipidemias en Colombia son limitados. El objetivo primario de este estudio fue describir la frecuencia de las dislipidemias; los objetivos secundarios fueron: la frecuencia de comorbilidades cardiovasculares, el uso de estatinas y otros hipolipemiantes, la frecuencia de intolerancia a estatinas, el porcentaje de pacientes en metas de c-LDL, y estimar la distribución del riesgo cardiovascular (RCV). MATERIALES Y MÉTODOS: Estudio transversal con recolección de datos retrospectiva que incluyó a 461 pacientes con diagnóstico de dislipidemia tratados en 17 centros cardiovasculares de alta complejidad en las 6 principales áreas geográficas y económicas de Colombia. RESULTADOS: La media (DE) de edad de los pacientes incluidos fue de 66,4 (±12,3) años. El 53,4% (246) eran mujeres. Las dislipidemias se distribuyeron así: dislipidemia mixta (51,4%), hipercolesterolemia (41,0%), hipertrigliceridemia (5,4%), hipercolesterolemia familiar (3,3%) y c-HDL bajo (0,7%). El medicamento más prescrito fue atorvastatina (75,7%), seguido de rosuvastatina (24,9%). El 55% del total de pacientes y el 28,6% de aquellos con enfermedad coronaria no estaban en metas de c-LDL a pesar del tratamiento. La frecuencia de intolerancia a estatinas fue del 2,6%. CONCLUSIONES: La dislipidemia mixta y la hipercolesterolemia son las dislipidemias más frecuentes. Un porcentaje considerable de pacientes en tratamiento, incluidos aquellos con enfermedad coronaria, no lograron sus objetivos de c-LDL. Este inadecuado control lipídico influye en el RCV y requiere un cambio en las estrategias terapéuticas, intensificando el tratamiento con estatinas o adicionando nuevos fármacos en los pacientes con mayor RCV


BACKGROUND AND OBJECTIVE: Data is scarce on the distribution of different types of dyslipidaemia in Colombia. The primary objective was to describe the frequency of dyslipidaemias. The secondary objectives were: frequency of cardiovascular comorbidity, statins and other lipid-lowering drugs use, frequency of statins intolerance, percentage of patients achieving c-LDL goals, and distribution of cardiovascular risk (CVR). MATERIALS AND METHODS: Cross-sectional study with retrospective data collection from 461 patients diagnosed with dyslipidaemia and treated in 17 highly specialised centres distributed into six geographic and economic regions of Colombia. RESULTS: Mean (SD) age was 66.4 (±12.3) years and 53.4% (246) were women. Dyslipidaemias were distributed as follows in order of frequency: mixed dyslipidaemia (51.4%), hypercholesterolaemia (41.0%), hypertriglyceridaemia (5.4%), familial hypercholesterolaemia (3.3%), and low c-HDL (0.7%). The most prescribed drugs were atorvastatin (75.7%) followed by rosuvastatin (24.9%). As for lipid control, 55% of all patients, and 28.6% of those with coronary heart disease, did not achieve their personal c-LDL goal despite treatment. The frequency of statin intolerance was 2.6% in this study. CONCLUSIONS: Mixed dyslipidaemia and hypercholesterolaemia are the most frequent dyslipidaemias in Colombia. A notable percentage of patients under treatment with lipid-lowering drugs, including those with coronary heart disease, did not achieve specific c-LDL goals. This poor lipid control may worsen patient's CVR, so that therapeutic strategies need to be changed, either with statin intensification or addition of new drugs in patients with higher CVR


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Dislipidemias/terapia , Dislipidemias/epidemiologia , Comorbidade , Colômbia/epidemiologia , Doenças Cardiovasculares/tratamento farmacológico , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Hipolipemiantes/uso terapêutico , Estudos Transversais , Dislipidemias/diagnóstico , Hipercolesterolemia/tratamento farmacológico , Hiperlipoproteinemia Tipo II/tratamento farmacológico , Hipertrigliceridemia/tratamento farmacológico
3.
Clin Investig Arterioscler ; 32(3): 101-110, 2020.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-32284160

RESUMO

BACKGROUND AND OBJECTIVE: Data is scarce on the distribution of different types of dyslipidaemia in Colombia. The primary objective was to describe the frequency of dyslipidaemias. The secondary objectives were: frequency of cardiovascular comorbidity, statins and other lipid-lowering drugs use, frequency of statins intolerance, percentage of patients achieving c-LDL goals, and distribution of cardiovascular risk (CVR). MATERIALS AND METHODS: Cross-sectional study with retrospective data collection from 461 patients diagnosed with dyslipidaemia and treated in 17 highly specialised centres distributed into six geographic and economic regions of Colombia. RESULTS: Mean (SD) age was 66.4 (±12.3) years and 53.4% (246) were women. Dyslipidaemias were distributed as follows in order of frequency: mixed dyslipidaemia (51.4%), hypercholesterolaemia (41.0%), hypertriglyceridaemia (5.4%), familial hypercholesterolaemia (3.3%), and low c-HDL (0.7%). The most prescribed drugs were atorvastatin (75.7%) followed by rosuvastatin (24.9%). As for lipid control, 55% of all patients, and 28.6% of those with coronary heart disease, did not achieve their personal c-LDL goal despite treatment. The frequency of statin intolerance was 2.6% in this study. CONCLUSIONS: Mixed dyslipidaemia and hypercholesterolaemia are the most frequent dyslipidaemias in Colombia. A notable percentage of patients under treatment with lipid-lowering drugs, including those with coronary heart disease, did not achieve specific c-LDL goals. This poor lipid control may worsen patient's CVR, so that therapeutic strategies need to be changed, either with statin intensification or addition of new drugs in patients with higher CVR.


Assuntos
Dislipidemias/tratamento farmacológico , Inibidores de Hidroximetilglutaril-CoA Redutases/administração & dosagem , Hipolipemiantes/administração & dosagem , Idoso , Idoso de 80 Anos ou mais , LDL-Colesterol/sangue , Colômbia/epidemiologia , Estudos Transversais , Dislipidemias/epidemiologia , Dislipidemias/fisiopatologia , Feminino , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases/efeitos adversos , Hipolipemiantes/efeitos adversos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
4.
Rev. colomb. gastroenterol ; 34(4): 350-355, oct.-dic. 2019. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-1092961

RESUMO

Resumen Un porcentaje importante de pacientes con gastritis crónica atrófica corporal autoinmune, o gastritis tipo A, desarrollan enfermedad autoinmune tiroidea (enfermedad de Graves o de Hashimoto) y viceversa, situación conocida como síndrome autoinmune tirogástrico (SAT), pero no se conoce su prevalencia, por lo que puede pasarse sin el diagnóstico completo. El desarrollo de la gastritis atrófica limita la absorción de la vitamina B12, lo que lleva a alteraciones hematológicas, neurológicas y metabólicas, por tanto, es importante realizar las pruebas necesarias para su diagnóstico y seguir de cerca la evolución de los pacientes. La detección serológica de los autoanticuerpos contra la glándula tiroides y el cuerpo gástrico muestran la etiología autoinmune y un estado inflamatorio con daño tisular. Todo paciente con enfermedad autoinmune debe ser valorado para descartar la presencia de otras patologías de etiología inmunológica.


Abstract A significant percentage of patients with chronic autoimmune atrophic body gastritis (type A gastritis) develop thyroid autoimmune disease (Graves' disease or Hashimoto's disease) and vice versa. This situation is known as thyrogastric syndrome. Its prevalence is unknown, due to incomplete diagnoses. Since the development of atrophic gastritis limits the absorption of vitamin B12 leading to hematological, neurological and metabolic alterations, it is important to perform necessary diagnostic tests and to closely monitor the evolution of patients. Serological detection of autoantibodies against the thyroid gland and the gastric body show the autoimmune etiology and an inflammatory state with tissue damage. Every patient with autoimmune disease should be evaluated to rule out the presence of other pathologies of immunological etiology.


Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Doenças Autoimunes , Síndrome , Doença de Hashimoto , Autoanticorpos , Glândula Tireoide , Helicobacter pylori , Gastrite Atrófica
5.
Rev. Fac. Med. (Bogotá) ; 64(3): 447-452, July-Sept. 2016. tab
Artigo em Inglês | LILACS | ID: biblio-956752

RESUMO

Abstract Introduction: During the medical internship year, students attend several hospitals and are observed and influenced by postgraduate students, general practitioners and other interns, who provide them with fundamental support regarding professional training. Bullying is defined as an aggressive behavior that occurs between a perpetrator and a victim in different scenarios and authority relationships, such as clinical practices at Medicine programs. Objective: To describe the perceived frequency of bullying among a group of interns of the Faculty of Medicine from Universidad Nacional de Colombia during internship. Materials and methods: A transversal analytical study was performed through a questionnaire applied to 82 medical interns of the School of Medicine from Universidad Nacional de Colombia. Results: The perceived frequency of bullying was 90%. Statistically significant differences were not found in the stratified analysis by sex or place of practice. In most cases, bullying was perpetrated by other interns, while residents and specialists showed a lower frequency. Conclusion: Perceived frequency of bullying was higher than expected according to the existing literature. These results can be used as a basis for new studies.


Resumen Introducción. Durante el año de internado, los estudiantes acuden a diversos hospitales y se encuentran bajo la mirada e influencia de estudiantes de posgrado, médicos generales, otros médicos internos y especialistas que brindan un apoyo importante en su formación. El matoneo o bullying es un comportamiento agresivo que se da entre un atacante y una víctima y que puede ocurrir en múltiples escenarios con diferentes relaciones de poder como las prácticas clínicas en la carrera de Medicina. Objetivo. Describir la frecuencia de matoneo percibida en un grupo de médicos internos de la Universidad Nacional de Colombia. Materiales y métodos. Estudio de corte transversal analítico realizado a través de una encuesta aplicada a 82 médicos internos de la Universidad Nacional de Colombia. Resultados. Se encontró una percepción de matoneo del 90% sin diferencias estadísticamente significativas al realizar el análisis estratificado por género y lugar de rotación. Las conductas de matoneo son llevadas a cabo en su mayoría por pares académicos y en menor medida por residentes y especialistas. Conclusiones. La percepción de matoneo resultó ser mayor a la reportada en la literatura. Estos resultados pueden emplearse como información de base para nuevos estudios.

6.
Asclepio ; 61(2): 67-100, 2009.
Artigo em Espanhol | MEDLINE | ID: mdl-21032940
7.
Rev. Asoc. Esp. Neuropsiquiatr ; 27(100): 111-126, jul.-dic. 2007.
Artigo em Espanhol | IBECS | ID: ibc-74577

RESUMO

Una crítica epistemológica a la idea neopositivista de «racionalidad científica» a partir de un análisis del racismo implícito en los conceptos científicos ortodoxos sobre la diversidad biológica humana durante el periodo de aceptación de las tesis darwinistas sobre el origen evolutivo de nuestra especie (AU)


An epistemologic critique to the neo-positivist concept of «scientific rationality». It is based on an analysis of biological racism, as it permeates orthodox scientific concepts about human diversity during the period in which evolutionary theories about human origins were accepted (AU)


Assuntos
Humanos , Preconceito , Racionalização , Biodiversidade , Evolução Biológica , Ética em Pesquisa , Política de Pesquisa em Saúde , Hominidae , Má Conduta Científica/história
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...